Cases 101 - 110 of 1,463
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
as 1:2023cv00580
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Moderna, Inc., ModernaTX, Inc. and Moderna US, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Johnson v. Satsuma Pharmaceuticals, Inc. et al
as 1:2023cv00565
Plaintiff:
William Johnson
Defendant:
Satsuma Pharmaceuticals, Inc., John Kollins, Heath Lukatch and others
Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00548
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Nexus Pharmaceuticals, Inc. v. Exela Pharma Sciences, LLC
as 1:2023cv00555
Counter Defendant:
Nexus Pharmaceuticals, Inc.
Defendant:
Exela Pharma Sciences, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al
as 1:2023cv00550
Plaintiff:
Novartis Pharmaceuticals Corporation and Astex Therapeutics Ltd.
Defendant:
MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2023cv00551
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al
as 1:2023cv00556
Plaintiff:
Mylan Pharmaceuticals Inc.
Defendant:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Ballard v. Satsuma Pharmaceuticals, Inc. et al
as 1:2023cv00544
Plaintiff:
William Ballard
Defendant:
Satsuma Pharmaceuticals, Inc., John Kollins, Heath Lukatch and others
Gilead Sciences, Inc. et al v. Lupin Limited et al
as 1:2023cv00508
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx Corp.
as 1:2023cv00490
Plaintiff:
Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals, Inc.
Defendant:
BendaRx Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
